Literature DB >> 26485097

The immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Khalid Bin Dhuban1, Ciriaco A Piccirillo.   

Abstract

PURPOSE OF REVIEW: This article presents a comprehensive review of the immunodysregulation, polyendocrinopathy, enteropathy and X-linked (IPEX) syndrome, covering both the clinical and molecular aspects of the disease. (Figure is included in full-text article.) RECENT
FINDINGS: The IPEX syndrome is a rare immunological disorder in humans caused by inheritable mutations in the FOXP3 gene, the master transcriptional regulator for the development and function of CD4 regulatory T (Treg) cells. Forkhead box protein 3 (FOXP3) Treg cells represent a unique T-cell lineage with inhibitory functions, and are responsible for immune homeostasis and tolerance to self and nonself antigens. Evidence shows that a Treg developmental deficiency or dysfunction underlies the severe, multiorgan, autoimmune disease of IPEX.
SUMMARY: An in-depth structural and functional analysis of the molecular domains of FOXP3 is essential for our understanding of the observed clinical heterogeneity and prognosis in IPEX.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26485097     DOI: 10.1097/ACI.0000000000000214

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  13 in total

1.  Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.

Authors:  Jared Klarquist; Kristen Tobin; Peyman Farhangi Oskuei; Steven W Henning; Manuel F Fernandez; Emilia R Dellacecca; Flor C Navarro; Jonathan M Eby; Shilpak Chatterjee; Shikhar Mehrotra; Joseph I Clark; I Caroline Le Poole
Journal:  Cancer Res       Date:  2016-09-12       Impact factor: 12.701

2.  Regulatory T cells: exploring mechanisms for future therapies.

Authors:  C A Piccirillo
Journal:  Clin Exp Immunol       Date:  2019-07       Impact factor: 4.330

Review 3.  Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

4.  A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.

Authors:  Alina Kurolap; Orly Eshach Adiv; Liza Konnikova; Lael Werner; Claudia Gonzaga-Jauregui; Maya Steinberg; Vanessa Mitsialis; Adi Mory; Moran Y Nunberg; Sarah Wall; Ron Shaoul; John D Overton; Alan R Shuldiner; Yaniv Zohar; Tamar Paperna; Scott B Snapper; Dror S Shouval; Hagit Baris Feldman
Journal:  J Clin Immunol       Date:  2019-05-11       Impact factor: 8.317

Review 5.  Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.

Authors:  Laurie S Davis; Andreas M Reimold
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

6.  Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69+ T Regulatory Cells.

Authors:  Marlen Vitales-Noyola; Brenda Oceguera-Maldonado; Perla Niño-Moreno; Nubia Baltazar-Benítez; Lourdes Baranda; Esther Layseca-Espinosa; Carlos Abud-Mendoza; Roberto González-Amaro
Journal:  Mediators Inflamm       Date:  2017-09-06       Impact factor: 4.711

7.  Analysis of Sodium Chloride Intake and Treg/Th17 Lymphocytes in Healthy Individuals and Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus.

Authors:  Marlen Vitales-Noyola; Esther Layseca-Espinosa; Lourdes Baranda; Carlos Abud-Mendoza; Perla Niño-Moreno; Adriana Monsiváis-Urenda; Yvonne Rosenstein; Roberto González-Amaro
Journal:  J Immunol Res       Date:  2018-07-09       Impact factor: 4.818

8.  Therapeutic vaccines for allergic disease.

Authors:  Danuta Gutowska-Owsiak; Graham S Ogg
Journal:  NPJ Vaccines       Date:  2017-05-08       Impact factor: 7.344

Review 9.  Forkhead-Box-P3 Gene Transfer in Human CD4+ T Conventional Cells for the Generation of Stable and Efficient Regulatory T Cells, Suitable for Immune Modulatory Therapy.

Authors:  Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2017-10-12       Impact factor: 7.561

10.  Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

Authors:  Federica Barzaghi; Laura Cristina Amaya Hernandez; Benedicte Neven; Silvia Ricci; Zeynep Yesim Kucuk; Jack J Bleesing; Zohreh Nademi; Mary Anne Slatter; Erlinda Rose Ulloa; Anna Shcherbina; Anna Roppelt; Austen Worth; Juliana Silva; Alessandro Aiuti; Luis Murguia-Favela; Carsten Speckmann; Magda Carneiro-Sampaio; Juliana Folloni Fernandes; Safa Baris; Ahmet Ozen; Elif Karakoc-Aydiner; Ayca Kiykim; Ansgar Schulz; Sandra Steinmann; Lucia Dora Notarangelo; Eleonora Gambineri; Paolo Lionetti; William Thomas Shearer; Lisa R Forbes; Caridad Martinez; Despina Moshous; Stephane Blanche; Alain Fisher; Frank M Ruemmele; Come Tissandier; Marie Ouachee-Chardin; Frédéric Rieux-Laucat; Marina Cavazzana; Waseem Qasim; Barbarella Lucarelli; Michael H Albert; Ichiro Kobayashi; Laura Alonso; Cristina Diaz De Heredia; Hirokazu Kanegane; Anita Lawitschka; Jong Jin Seo; Marta Gonzalez-Vicent; Miguel Angel Diaz; Rakesh Kumar Goyal; Martin G Sauer; Akif Yesilipek; Minsoo Kim; Yesim Yilmaz-Demirdag; Monica Bhatia; Julie Khlevner; Erick J Richmond Padilla; Silvana Martino; Davide Montin; Olaf Neth; Agueda Molinos-Quintana; Justo Valverde-Fernandez; Arnon Broides; Vered Pinsk; Antje Ballauf; Filomeen Haerynck; Victoria Bordon; Catharina Dhooge; Maria Laura Garcia-Lloret; Robbert G Bredius; Krzysztof Kałwak; Elie Haddad; Markus Gerhard Seidel; Gregor Duckers; Sung-Yun Pai; Christopher C Dvorak; Stephan Ehl; Franco Locatelli; Frederick Goldman; Andrew Richard Gennery; Mort J Cowan; Maria-Grazia Roncarolo; Rosa Bacchetta
Journal:  J Allergy Clin Immunol       Date:  2017-12-11       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.